Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04592562 · ClinicalTrials.gov registry record · NA

Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT04592562 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04592562, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Knee Injury and Osteoarthritis Outcome (KOOS) score, and Oswestry Disability Index.

Interventions

  • DEVICE the Terumo Hydropearl® microspheres device

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-09-22
Est. Completion 2024-05-28
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT04592562

The ClinicalTrials.gov registry entry for NCT04592562 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which the Terumo Hydropearl® microspheres device is the first listed.

NCT04592562 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04592562 about?

NCT04592562 is a clinical study titled "Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis". The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Kne...

What is the current status of trial NCT04592562?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-09-22. Estimated completion is 2024-05-28.

What interventions are being tested in trial NCT04592562?

The interventions under investigation include: the Terumo Hydropearl® microspheres device (DEVICE).

Who is sponsoring clinical trial NCT04592562?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.